Clinical Trial Details
| Trial ID: | L1698 |
| Source ID: | NCT06185660 |
| Associated Drug: | Sodium Zirconium Cyclosilicate (Szc) |
| Title: | A National, Multicenter, Prospective, Observational Study to Assess Patient Characteristics, Treatment Algorithms and Disease Management of Hyperkalaemia Patients With Chronic Kidney Disease or Under Dialysis or With Heart Failure, Treated With Sodium Zirconium Cyclosilicate in Greece |
| Acronym: | SHIELD |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | Hyperkalaemia |
| Interventions: | DRUG: sodium zirconium cyclosilicate (SZC) |
| Outcome Measures: | Primary: To record the treatment patterns and characteristics of patients with hyperkalaemia receiving Sodium Zirconium Cyclosilicate (SZC), To describe the treatment patterns and patient characteristics of hyperkalaemia patients receiving Sodium Zirconium Cyclosilicate (SZC), by recording any pharmacological and other intervention administered, including dose and frequency of administration, Enrollment time point, 3 months after enrollment, 6 months after enrollment | |
| Sponsor/Collaborators: | Sponsor: AstraZeneca |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | |
| Enrollment: | 125 |
| Study Type: | OBSERVATIONAL |
| Study Designs: | Observational Model: |Time Perspective: p |
| Start Date: | 2024-02-09 |
| Completion Date: | 2025-01-03 |
| Results First Posted: | |
| Last Update Posted: | 2025-02-03 |
| Locations: | Research Site, Alexandroupolis, 68100, Greece|Research Site, Athens, 10676, Greece|Research Site, Athens, 11527, Greece|Research Site, Athens, 12462, Greece|Research Site, Athens, 15123, Greece|Research Site, Heraklion, 71500, Greece|Research Site, Larissa, 41110, Greece|Research Site, Patra, 26504, Greece|Research Site, Thessaloniki, 54636, Greece|Research Site, Thessaloniki, 57010, Greece |
| URL: | https://clinicaltrials.gov/show/NCT06185660 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|